[Clostridium clostridiiforme vertebral osteomyelitis].
Tekaya
R
R
Saidane
O
O
Abdelmoula
L
L
Ben Hadj Yahia
C
C
Manamani
L
L
Chaabouni
L
L
Zouari
R
R
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002939:Ciprofloxacin / Q000627:therapeutic use*; D003013:Clostridium / Q000187:drug effects; D003015:Clostridium Infections / Q000175:diagnosis*; D004359:Drug Therapy, Combination; D006801:Humans; D007121:Immunocompetence; D008297:Male; D008795:Metronidazole / Q000627:therapeutic use*; D015242:Ofloxacin / Q000627:therapeutic use*; D010019:Osteomyelitis / Q000382:microbiology*; D013131:Spine / Q000382:microbiology*; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D008795:Metronidazole; D002939:Ciprofloxacin; D015242:Ofloxacin